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Traditional Chinese medicine (TCM) has been widely used in China for thousands of years to treat and prevent diseases. TCM has
been proven safe and effective, and it is being considered as one of the important types of complementary and alternative medicine
and receives increasing attention worldwide. The dried root of Polygonum cuspidatum Sieb. et Zucc. (also known as “Hu Zhang” in
Chinese) is one of themedicinal herbs listed in the Pharmacopoeia of the People’s Republic of China. HuZhang is widely distributed
in the world. It can be found in Asia and North America and is used as folk medicine in countries such as Japan and Korea.
In China, Hu Zhang is usually used in combination with other TCM herbs. The therapeutic uses of those Hu Zhang-containing
TCM prescriptions or formulations are for treating cough, hepatitis, jaundice, amenorrhea, leucorrhea, arthralgia, burns and snake
bites. Recent pharmacological and clinical studies have indicated that Hu Zhang has antiviral, antimicrobial, anti-inflammatory,
neuroprotective, and cardioprotective functions. This review gives a summary of the reported therapeutic effects of the active
compounds and the different extracts of Hu Zhang.
1. Introduction
The definition of complementary and alternative medicine
(CAM) is broad. In general, CAM refers to a group of health
care systems, practices, and medications that are not con-
sidered conventional or orthodox. CAM includes traditional
Chinese medicine (TCM), acupuncture, Ayurveda, massage
therapies, and mind-body therapies (such as yoga). It is often
used together with conventional medicine. It is common that
patients with chronic diseases turn to CAM therapies for
better treatment effects, fewer side effects, or for relieving side
effects of drugs. TCM, a well-known CAM, has been used to
treat a variety of diseases for thousands of years [1–3]. Panax
ginseng, Pinella ternate, Salviae miltiorrhizae and Arisaema
japonicum are some commonly known TCMs [1, 4, 5].
As one of the important types of CAM, TCM is receiving
increasing attention among scientists worldwide. For treating
some complex diseases such as diabetes mellitus and cancer,
TCM is one of the common alternatives of conventionalmed-
ications. In recent decades, researchers frommainlandChina,
Hong Kong, and Taiwan have focused on the investigation
of various TCM herbs and their active compounds and have
discovered therapeutics that are based on single compounds,
such as salvicine for anticancer activity and artemisinin for
malaria treatment [6].
Polygonum cuspidatum Sieb. et Zucc. is a herbaceous
perennial plant. It is a member of the genus Polygonum in
the family Polygonaceae, which grows in Asia and North
America. In China, there are about 80 species of Polygonum
used in TCM [7]. Its dried root (Figure 1) is officially listed in
the Pharmacopoeia of the People’s Republic of China under
the name “Hu Zhang” [7]; it is also used as folk medicine in
Japan and Korea. From the perspective of TCM theory, Hu
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Figure 1: Photo of the dried root of Polygonum cuspidatum (Hu
Zhang).
Zhang is used to remove jaundice and clear heat-toxin so as
to promote blood circulation, dispel stasis, expel wind and
dampness, dissipate phlegm, and suppress cough. Therefore,
Hu Zhang is commonly prescribed by TCM practitioners
for the treatment of cough, hepatitis, jaundice, amenorrhea,
leucorrhoea, arthralgia, hyperlipidemia scald and bruises,
snake bites, and carbuncles [8].
Hu Zhang is frequently used as a hepatoprotective and
cholagogic drug in TCM. Its effects on hypertension, hy-
perlipidemia, and cardiovascular and neurodegenerative dis-
eases have also been intensively investigated, both experi-
mentally and clinically.
The purpose of this review is to provide a comprehensive
overview of the pharmacological effects of Hu Zhang and to
attract the attention of more researchers towards its use as
an alternative medicine in clinical settings. Additionally, the
major chemical components of Hu Zhang are summarized.
2. Active Ingredients Found in Hu Zhang
Hu Zhang contains various classes of chemicals. Stilbenes
including resveratrol, polydatin, and anthraquinones such as
emodin and its glycoside are the major compounds in Hu
Zhang. Hu Zhang also contains flavonoids such as quercetin
and (+)-catechin. The major active ingredients isolated
from this herb are emodin, physcion, emodin 8-O-𝛽-D-
glu-copyranoside, 2-methoxy-6-acetyl-7-methyljuglone, cit-
reorosein, (+)-catechin, polydatin, and resveratrol (Table 1).
Recently, some new compounds such as polygonins A and
B were also isolated from Hu Zhang [9]. However, their
pharmacological effects are not yet identified.
3. Pharmacological Activities
Hu Zhang has been used in many TCM formulas to treat
various ailments. It is also used as folk medicine to promote
general physical health. Pharmacological researches and
clinical studies have indicated that Hu Zhang extract and
its major compounds possess antivirus, antimicrobial, anti-
inflammatory, neuroprotective, and cardioprotective activi-
ties (Tables 1 and 2).
3.1. Antiviral Activities. Chronic hepatitis B virus (HBV)
infection remains one of the most challenging global health
problems, with more than 350 million people infected and at
risk of hepatic decompensation, cirrhosis, and hepatocellular
carcinoma. Potent oral antiviral agents have been approved
to treat hepatitis B since 1998. Therapy with interferon
alpha and nucleosides or nucleotide analogues is effective to
treat hepatitis B by suppressing virus replication, reducing
hepatitis activity, and preventing disease progression [10].
Meanwhile, almost 50 million people worldwide are infected
with human immunodeficiency virus (HIV). The number
of HIV-positive people continues to increase at an alarming
rate in China and some other Asian countries [11]. Although
current anti-HBV/HIV drugs could improve the quality of
life for those infected patients, emerging drug resistance has
driven the need to search for new anti-HBV/HIV agents and
targets.
Many natural compounds that exhibit anti-HIV activity
have been identified. These include alkaloids [12], flavonoids
[13], and polyphenols [14]. 70% EtOH extract of Hu Zhang
was demonstrated to have inhibitory function against HIV-
1-induced syncytium formation in C8166 lymphocytes with
a 50% effective concentration (EC
50
) of 13.94 ± 3.41 𝜇g/mL.
Through bioactivity-guided fractionation of Hu Zhang,
(E)-resveratrol, 5,7-dimethoxyphthalide, (+)-catechin, and
emodin 8-O-𝛽-D-glucopyranoside were shown to exhibit
fairly strong antiviral activity against HIV-1-induced cyto-
pathic effects in C8166 lymphocytes at noncytotoxic concen-
trations. This provides evidence for the “heat-clearing and
detoxifying” functions of Hu Zhang and its antiviral activities
[15].
Researchers have explored the efficacy of Hu Zhang
extracts against HBV inHepG
2
2.2.15 human hepatoblastoma
cell line by quantitative real-time polymerase chain reaction
in search of effective antiviral agents. The expressions of
HBeAg and HBsAg were determined by enzyme-linked
immunosorbent assay. Results indicated that ethanol extract
of Hu Zhang could inhibit the production of HBV with an
effective minimal dose of 10 𝜇g/mL. Both water and ethanol
extracts of Hu Zhang significantly increased the expression
of HBsAg, whereas a higher dose of water extract (30𝜇g/mL)
inhibited the expression of HBeAg. However, both extracts
showed some degree of cytotoxicity to the host cells [16]. It is
not known whether the anti-HBV effect and cytotoxicity are
due to the same compound or active fraction of the extracts.
Further chemical and biological analyses are required to
purify the active component(s) in Hu Zhang.
3.2. Antimicrobial Effects. Dental caries is a dental biofilm-
related oral disease. Chlorhexidine and antibiotics, generally
used as anti-biofilm agents, have shown undesirable side
effects such as extrinsic staining and bacterial resistance. Hu
Zhang is shown to be a promising alternative medicine for
preventing dental caries [17]. It has been reported that a
Hu Zhang fraction (called F1), that is mainly composed of
physcion, emodin, and resveratrol, could enhance fluoride
activity against Streptococcusmutans (S.mutans) virulence. F1
also showed inhibitory effects against F-ATPase activity and
acid production of S.mutans in biofilms.Therefore, F1may be
useful for preventing oral diseases, particularly those related
to dental biofilm [18].
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Vibrio vulnificus (V. vulnificus)could cause fetus sep-
ticemia with mortality rate of more than 50% within a
few days after infection [19]. Research has demonstrated
that the ethanol extract of Hu Zhang and its active com-
pound, emodin, possess significant protective effects against
V. vulnificus cytotoxicity and infection. It was identified that
ethanol extract of Hu Zhang and emodin could protect RAW
264.7 andHela cells fromV. vulnificus-induced cytotoxicity in
vitro.They could also inhibitV. vulnificus growth and survival
in seawater and heart infusion broth. Pretreatment of ethanol
extract of Hu Zhang (200mg/kg) or emodin (20mg/kg) can
protect 8-week-old CD-1 mice infected with V. vulnificus in
vivo [20]. This further suggests the antimicrobial activity of
Hu Zhang.
3.3. Anti-Inflammatory Effects. Inflammation could cause
a variety of diseases such as autoimmune diseases [21],
neurodegenerative diseases [22], cardiovascular diseases [23],
or cancer [24]. Nonsteroidal anti-inflammatory drugs and
cyclooxygenase-2 (COX-2) inhibitors are commonly used
to treat diseases related to inflammation, but the adverse
effects on the gastrointestinal and cardiovascular systems
have limited their clinical applications.
The pathogenesis of arthritis, hepatitis, and acute lung
injury (ALI) are somehow related to inflammation [25–
27]. Thus, inflammatory response plays an essential role
in the progression of these diseases. Although many anti-
inflammatory drugs are available clinically to treat arthritis,
hepatitis, and ALI, their efficacy is limited and they always
come with side effects. Researches that aim at identifying
botanical drugs with little toxicity and good therapeutic
performance have been increasing [3, 28]. Extensive studies
have indicated that the extract of Hu Zhang or its major con-
stituents have anti-inflammatory activities that may benefit
patients with arthritis, hepatitis or ALI.
The anti-inflammatory effects of the ethyl acetate extract
of Hu Zhang were investigated in Freund’s complete adju-
vant (FCA)-induced arthritis model and serotonin-induced
paw edema model in Sprague-Dawley rats in vivo. The
ethyl acetate extract of Hu Zhang at 100 and 200mg/kg
significantly suppressed serotonin-induced swelling since
12min after serotonin treatment. Consistently, in the FCA-
induced arthritis model, the ethyl acetate extract of Hu
Zhang at 200mg/kg significantly suppressed FCA-induced
joint swelling within 3 days, whereas the ethyl acetate extract
of Hu Zhang at 100mg/kg showed similar suppression within
5 days. Furthermore, the extract effectively inhibited positive
responses of c-reactive protein and rheumatoid factor when
compared with the untreated control in the FCA-induced
arthritis model. Taken together, these findings suggested that
the ethyl acetate extract of Hu Zhang could be a potent agent
for rheumatoid arthritis treatment [29].
Intravenous administration of lipopolysaccharide (LPS)
could lead to activation of various inflammatory mediators
such as phospholipase A
2
(PLA
2
) in the ALI rat model in
vivo. Polydatin, an active compound of Hu Zhang, could up-
regulate Clara cell secretory protein (CCSP) to inhibit PLA
2
,
which may be one of the crucial protection mechanisms of
polydatin in LPS-induced ALI. For further investigation, the
human bronchial epithelia cells transformed by the SV40
T-antigen were chosen as the model to study the effect
of polydatin on CCSP in vitro. Polydatin can promote the
expression of CCSP in normal and LPS-stimulated cells
[30]. Additionally, polydatin could protect mice against
carbon tetrachloride-induced liver injury through anti-
inflammatory and antioxidative effects in vivo. These effects
are achieved through suppressing levels of hepatic malon-
dialdehyde (MDA), tumour necrosis factor-alpha (TNF-𝛼),
interleukin 1 beta (IL-1𝛽), COX-2, inducible nitric oxide
synthase (iNOS), and nuclear factor-kappaB (NF𝜅B) and
enhancing levels of superoxide dismutase (SOD), glutathione
(GSH), glutathione transferase (GST), catalase (CAT), glu-
tathione peroxidase (GPx), and transforming growth factor-
beta 1 (TGF-𝛽
1
) in the liver tissue. Therefore, polydatin may
help people cope with oxidative stress and inflammation-
related liver damage [31].
Hu Zhang extract (standardized to contain 20% trans-
resveratrol) demonstrated comprehensive suppressive effects
on inflammatory and oxidative stress. These effects are
achieved through decreasing levels of TNF-𝛼, interleukin,
intranuclear NF𝜅B binding, c-jun-N-terminal kinase 1 (JNK
1), phosphotyrosine phosphatase-1B (PTP-1B), as well as
reactive oxygen species (ROS) generation in mononuclear
cells [32].
Emodin, an active compound in Hu Zhang, was shown
to inhibit the expression of inflammatory-associated genes
including iNOS, TNF-𝛼, interleukin-10, I𝜅B kinase (IKK)-
alpha, and IKK-gamma and to inhibit the nuclear translo-
cation of NF𝜅B on LPS-induced inflammatory responses in
RAW 264.7 macrophages [33].
Citreorosein, an anthraquinone derivative isolated from
Hu Zhang, inhibited COX-2-dependent prostaglandin D
2
generation and COX-2 expression in mouse bone marrow-
derived mast cells stimulated with stem cell factor. The effect
of citreorosein was achieved through inhibition of the Akt
and JNK pathways [34].
Ethanolic solution of Hu Zhang and resveratrol were
demonstrated to inhibit the development of edema and
leukocyte infiltration in the 12-O-tetradecanoylphorbol-13-
acetate-(TPA-) induced ear edema in mice in vivo [35]. Topi-
cal application of resveratrol also significantly inhibited TPA-
induced COX-2 expression via modulation of the IKK-NF𝜅B
signaling cascade in mouse skin in vivo. This investigation
provides evidence for the potential uses of Hu Zhang in
cosmeceutical and dermatological products [36].
3.4. Neuroprotective Activities. Preventing neuronal death is a
top priority for treating neurological diseases [37]. Oxidative
stress is implicated as a causative factor in neuronal death in
neurodegenerative disorders [38]. There is a growing interest
in searching for neuroprotective agents fromnatural products
since they contain compounds with high antioxidant power
[39]. Several studies have reported the neuroprotective effects
of Hu Zhang extract or its major compounds such as
polydatin, emodin 8-O-𝛽-D-glucopyranoside, 2-methoxy-6-
acetyl-7-methyljuglone, and resveratrol.
It has been found that polydatin could reduce the vol-
ume of cerebral infraction and improve rat neurological
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deficits induced by transient middle cerebral artery occlusion
(MCAO). Polydatin also protects the brain from injury
by inhibiting the expression of cell adhesion molecules,
in particular vascular cell adhesion molecule 1 (VCAM-1),
intracellular adhesion molecule 1 (ICAM-1), L-selectin, and
E-selectin. These findings suggest that polydatin may be a
potential agent for treatment of brain injury associated with
stroke [40]. Additionally, polydatin couldmarkedly attenuate
cognitive deficits induced by chronic cerebral hypoperfusion
in rats, decrease the production of MDA and increase the
activities of SOD and CAT. Additionally, polydatin has also
exerted the protective effects in oxygen glucose deprivation
(OGD) model. These results demonstrate that polydatin
could offer a novel therapeutic strategy for the treatment
of vascular dementia [41]. Apart from polydatin, emodin 8-
O-𝛽-D-glucopyranoside (an anthraquinone) has been sug-
gested to have protective effects against cerebral ischemia-
reperfused injury in vivo and glutamate-induced damage
in cortical cells in vitro. It decreased MDA level in the
brain and increased SOD activity. Moreover, emodin 8-O-
𝛽-D-glucopyranoside reduced the neurological deficit score
and the cerebral infraction area [42]. Therefore, one of the
important pathways forHuZhang to elicit its neuroprotective
effects may relate to its antioxidant properties.
2-Methoxy-6-acetyl-7-methyljuglone, another anthra-
quinone isolated from Hu Zhang, could effectively protect
PC12 cells against cytotoxicity induced by tert-Butyl hydrop-
eroxide. The neuroprotective effect of 2-methoxy-6-acetyl-
7-methyljuglone may contribute to its antioxidant effect and
ability to decrease the expressions of the phosphorylation of
ERK1/2, JNK, and p38 MAPK [43].
Senescence-accelerated mouse (SAM), an aging model,
was used for brain aging and anti-aging pharmacology stud-
ies. Resveratrol extracted from Hu Zhang increased the SOD
and GPx activities, while decreasing MDA level in SAM in
vivo. Resveratrol could improve neuromuscular coordination
and sensorimotor ability in tightrope test. It could also
enhance the learning and memory capacity in Morris water
maze test in SAM.These results indicate that resveratrol may
exhibit therapeutic potential for age-related conditions [44].
3.5. Cardioprotective Activities. Hyperlipidemia is one of the
major risk factors of cardiovascular diseases such as coronary
heart disease and atherosclerosis. Natural products have been
shown to be effective in modulating serum lipid profile
under hyperlipidemic [4] or hypercholesterolemic [45, 46]
conditions. Polydatin couldmarkedly reduce the serum levels
of triglycerides, total cholesterol, and low-density lipoprotein
cholesterol in hyperlipidemic rabbits [47]. For the prominent
beneficial effect on serum lipid profile, it is worth exploring
polydatin as a hypidolipemic drug or health supplement for
patients with hyperlipidemia and/or hypercholesterolemia.
Cardiomyocytes are sensitive to ischemia/reperfusion
(I/R). Polydatin intravenously administrated strongly pro-
tects the myocardium against I/R injury by activating pro-
tein kinase C (PKC) and opening mitochondrial ATP-
sensitive K+ channel. Meanwhile, pretreatment of polydatin-
attenuated changes inMDAand SOD, suggests that polydatin
might protect myocardial against I/R injury through free
radical-elimination mechanism. The findings demonstrated
that polydatin may have therapeutic potential in the treat-
ment of cardiac reperfusion injury and other cardiovascular
diseases that are related to mitochondrial oxidative damage
in etiology [48]. Polydatin also has beneficial effects in
ventricular remodeling induced by isoproterenol in mice and
by abdominal aortic banding in rats in vivo. Its pharma-
cological effects on the heart are at least in part mediated
by inhibiting the activation of renin-angiotensin-aldosterone
system (RAAS) and decreasing the excretion of endothelin
1, TNF-𝛼, and angiotensin II. Therapeutic use of polydatin
might have potential in early treatment of chronic heart
failure and improvement of ventricular remodeling [49].
Resveratrol could also protect the heart from I/R injury,
prevent cardiac hypertrophy in hypertensive animals, and
reduce the progression of atherosclerosis. It is believed that
endothelial NOS, estrogen receptor alpha (ER𝛼), Akt kinase,
NF𝜅B, and survival activating factor enhancement pathway
may mediate the aforementioned cardiovascular effects of
resveratrol [50]. Resveratrol supplementation elevated apo-
AI/apo B ratio and levels of HDL-cholesterol, and decreased
plasma LDL-C concentration and hepatic HMG-CoA reduc-
tase activity. Moreover, in resveratrol-supplemented apo E−/−
mice, ICAM-1 and VCAM-1 in atherosclerotic vessels were
diminished, thereby delaying the progression of atherosclero-
sis [51]. Pretreatedwith resveratrol improved cardiac function
and reducement myocardial infarct size and cardiomyocyte
apoptosis in the ischemic/reperfused rats heart. Resveratrol
protected the ischemic heart by restoring the IR-induced
altered microRNA expressions [52]. All of the above findings
suggest that polydatin and resveratrol are potential bioactive
compounds for treating cardiovascular diseases.
3.6. Other Activities. In recent years, resveratrol has become
widely appreciated in the field of botanical dietary sup-
plements [56]. Resveratrol, a dietary phenolic compound,
in fruits and medicinal plants, exerts chemopreventive and
antitumor effects [57]. Administration of resveratrol was
found to protect salivary glands against radiation-induced
dysfunction in mice. It can reverse the reduction of saliva
secretion and restore salivary amylase and SOD activity.
Resveratrol has great potential as a treatment for successful
radiotherapy in clinical practice [58]. Resveratrol impeded
cancer stem cells’ (CSCs) properties through the activation
of p53. Furthermore, resveratrol suppressed the stemness
and epithelial-mesenchymal transition (EMT) through reac-
tivating p53 and inducing miR-145 and miR-200c [59]. In
MCF-7 breast cancer cells, resveratrol with doxorubicin can
inhibit HSP expression and improve the therapeutic effects of
doxorubicin probably bymeans of cell death induction.These
findings suggest that resveratrol may be an effective adjuvant
in breast cancer therapy [60].
In addition, Hu Zhang’s methanolic extract and active
compounds, such as emodin and emodin 8-O-𝛽-D-gluco-
pyranoside, were found to enhance the proliferation of
MCF-7, an estrogen-sensitive cell line, in a concentration-
dependentmanner. It was found that emodin exerts estrogen-
like activities by binding to human ER𝛼 and ER𝛽. It may
be useful for hormone replacement therapy against human
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menoxenia and post-menopausal diseases [53]. Citreorosein,
a naturally occurring anthraquinone derivative from Hu
Zhang, was found to exert estrogenic activity by using a
recombinant assay [55].
Three Hu Zhang’s anthraquinones, physcion, emodin,
and citreorosein, showed moderate to strong tyrosinase
inhibition. Thus, they may be used as skin whitening agents
in place of kojic acid. Among these anthraquinones, physcion
exhibited the most potent tyrosinase inhibition and showed
higher permeability into the skin [54], suggesting its potential
in cosmeceutical and dermatological uses.
4. Conclusions
Conventional medicines provide significant therapeutic ben-
efits, but they also have side effects and they may have prob-
lem of drug resistance when same drugs are used over a long
period of time. The search for TCM with fewer side effects
and little toxicity has gained momentum over the years. The
use of TCM has a long history with proven effectiveness and
safety. Hu Zhang has been prescribed in China for medical
purposes for thousands of years. Reports in the literature have
demonstrated Hu Zhang’s potential beneficial effects such
as antimicrobial, antiviral, anti-inflammatory, estrogenic,
neuroprotective, and cardioprotective activities. Yet, there is
no research reporting/investigating the toxicity of Hu Zhang.
Based on the results from both clinical tests and research
tests conducted in laboratories, several active compounds of
Hu Zhang have demonstrated positive effects on a variety of
diseases. Hu Zhang might be a valuable alternative medicine
that could be integrated into conventional treatments. More
researches on the beneficial effects of Hu Zhang and its
potential risks as an alternative medicine are needed.
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